Journal of Hematopathology

, Volume 6, Issue 1, pp 39–43 | Cite as

Aggressive genetic “double-hit” B-cell lymphoma following renal transplantation: case report

  • Nathanael G. Bailey
  • Bryan L. Betz
  • Diane Roulston
  • Kojo S. J. Elenitoba-Johnson
  • Megan S. Lim
Case Report


B-cell lymphomas with two oncogenic chromosomal translocations (“double-hit” lymphomas [DHL]) often exhibit morphologic and immunophenotypic features intermediate between conventional diffuse large B-cell lymphoma and Burkitt's lymphoma (BL). DHL are highly aggressive neoplasms that respond poorly to current treatment strategies. A case of DHL that arose in a patient with a history of renal transplantation, diagnosed in a skin biopsy, is described. The lymphoma had morphologic features reminiscent of BL; however, in addition to the IGH@-MYC fusion, BCL6 was translocated to chromosome 13 in the presence of a complex karyotype. This case exhibits very unusual features: lymphomas with both MYC and BCL6 translocations are rare, and posttransplant DHL have virtually never been described. The importance of identifying patients with DHL is emphasized, as these patients require alternative therapeutic approaches.


Double-hit Lymphoma Posttransplant lymphoproliferative disorder BCL6 


  1. 1.
    Kluin PM, Harris NL, Stein H, Leoncini L, Raphaël M, Campo E, Jaffe ES (2008) B-cell Lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 265–6Google Scholar
  2. 2.
    Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans H, Boerma E, Kluin PM (2011) Double hit B-cell lymphomas. Blood 117:2319–2331PubMedCrossRefGoogle Scholar
  3. 3.
    Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE, Bernd H, Cogliatti SB, Dierlamm J, Feller AC, Hansmann M, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink H, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker H, Spang R, Loeffler M, Trümper L, Stein H, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419–30PubMedCrossRefGoogle Scholar
  4. 4.
    Snuderl M, Kolman OK, Chen Y, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR (2010) B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 34:327–40PubMedCrossRefGoogle Scholar
  5. 5.
    Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019–32PubMedCrossRefGoogle Scholar
  6. 6.
    Pillai R, Sathanoori M, Swerdlow S (2011) Clinicopathologic features of double hit lymphomas with BCL6 and MYC gene rearrangements. Mod Pathol 24:315AGoogle Scholar
  7. 7.
    Galiègue-Zouitina S, Quief S, Hildebrand MP, Denis C, Detourmignies L, Laï JL, Kerckaert JP (1999) Nonrandom fusion of L-plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma. Genes Chromosom Cancer 26:97–105PubMedCrossRefGoogle Scholar
  8. 8.
    Swerdlow SH, Webber SA, Chadburn A, Ferry JA (2008) Post-transplant lymphoproliferative disorders. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 343–9Google Scholar
  9. 9.
    Caillard S, Lelong C, Pessione F, Moulin B (2006) Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry. Am J Transplant 6:2735–2742PubMedCrossRefGoogle Scholar
  10. 10.
    Ghobrial IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, Ansell SM, Gores GJ, Stegall MD, McGregor CG (2005) Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation 79:244–7PubMedCrossRefGoogle Scholar
  11. 11.
    Cesarman E, Chadburn A, Liu Y, Migliazza A, Dalla-Favera R, Knowles DM (1998) BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 92:2294–2302PubMedGoogle Scholar
  12. 12.
    Djokic M, Le Beau MM, Swinnen LJ, Smith SM, Rubin CM, Anastasi J, Carlson KM (2006) Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosom Cancer 45:313–8PubMedCrossRefGoogle Scholar
  13. 13.
    Vakiani E, Nandula SV, Subramaniyam S, Keller CE, Alobeid B, Murty VV, Bhagat G (2007) Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Hum Pathol 38:315–25PubMedCrossRefGoogle Scholar
  14. 14.
    Seegmiller AC, Garcia R, Huang R, Maleki A, Karandikar NJ, Chen W (2010) Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas. Mod Pathol 23:909–20PubMedCrossRefGoogle Scholar
  15. 15.
    Mitelman F, Johansson B and Mertens F. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2012) Available at: Accessed 19 March 2012

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Nathanael G. Bailey
    • 1
  • Bryan L. Betz
    • 1
  • Diane Roulston
    • 1
  • Kojo S. J. Elenitoba-Johnson
    • 1
  • Megan S. Lim
    • 1
  1. 1.Department of PathologyUniversity of MichiganAnn ArborUSA

Personalised recommendations